New Computer Models Open Door to Far More Targeted Antibiotics

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only specific bacteria in specific parts of the body.

As it stands, antibiotics kill bacteria indiscriminately. Because the drugs are used so widely, increasing numbers of dangerous bugs are growing resistant, threatening one of modern medicine’s most important weapons against disease.

UVA's new approach, on the other hand, would dramatically limit how often bacteria are exposed to antibiotics, reducing the chance they could become resistant to antibiotics. Further, the approach would represent a significant step forward for precision medicine, allowing doctors to better tailor treatments to individual patients’ needs. Instead of taking an antibiotic that kills bacteria regardless of whether helpful or harmful, patients could be given antibiotics that target specific bacteria causing a specific problem in a specific area of the body.

"Many biomedical challenges are incredibly complex, and computer models are emerging as a powerful tool for tackling such problems," said researcher Jason Papin, PhD, of UVA's Department of Biomedical Engineering. "We're hopeful that these computer models of the molecular networks in bacteria will help us develop new strategies to treat infections."

UVA's new approach was made possible by a herculean effort by Papin, PhD student Emma Glass and their collaborators. Working with Andrew Warren, PhD, of UVA's Biocomplexity Institute, the researchers in Papin’s lab developed sophisticated computer models of every human bacterial pathogen with sufficient genetic information available.

Glass then analyzed all those models and identified shared traits among the bacteria. This analysis yielded the discovery that bacteria in certain parts of the body, such as the stomach, tended to share metabolic properties. Basically, where they live shapes how they function.

"Using our computer models we found that the bacteria living in the stomach had unique properties," Glass said. "These properties can be used to guide design of targeted antibiotics, which could hopefully one day slow the emergence of resistant infections."

The shared similarities among the microbes in different locales could be the Achilles' heel for harmful bacteria in our bodies. With further research, doctors may be able to target specific types of bacteria in specific areas, reducing the need for broad-spectrum antibiotics.

Putting their computer-modeling approach to the test, Papin and his team have already found that they could inhibit the growth of harmful stomach bugs in lab experiments. That’s a promising sign for the future potential of their computer-modeling approach.

"We still have much to do to test these ideas for other bacteria and types of infections," Papin said. "but this work shows the incredible promise of data science and computer modeling for tackling some of the most important problems in biomedical research."

Glass EM, Dillard LR, Kolling GL, Warren AS, Papin JA.
Niche-specific metabolic phenotypes can be used to identify antimicrobial targets in pathogens.
PLoS Biol. 2024 Nov 18;22(11):e3002907. doi: 10.1371/journal.pbio.3002907

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...